No selection of mutations. 908 raises genetic resistance barrier
MMW Fortschritte der Medizin 145 Spec No 1: 41
2003
ISSN/ISBN: 1438-3276 PMID: 15011586 Document Number: 559832
Document emailed within 1 workday
Related Documents
Hsie, A.W.; Brimmer, P.A.; Machanoff, R.; Hsie, M.H. 1977: Further evidence for the genetic origin of mutations in mammalian somatic cells: the effects of ploidy level and selection stringency on dose-dependent chemical mutagenesis to purine analogue resistance in Chinese hamster ovary cells Mutation Research 45(2): 271Mironov, V.N.; Gordeev, V.K. 1984: Selection, analysis and mapping of mutations in the gene for resistance to kanamycin in plasmid RP4 Genetika 20(9): 1457-1462
Frankel, J.; Jenkins, L.M.; Doerder, F.P.; Nelsen, E.M. 1976: Mutations affecting cell division in Tetrahymena pyriformis. I. Selection and genetic analysis Genetics 83(3 Pt.2): 489-506
Haarer, B.K.; Corbett, A.; Kweon, Y.; Petzold, A.S.; Silver, P.; Brown, S.S. 1996: SEC3 mutations are synthetically lethal with profilin mutations and cause defects in diploid-specific bud-site selection Genetics 144(2): 495-510
Kadowaki, T.; Kasuga, M. 1991: Mutations in the insulin receptor gene in patients with genetic forms of insulin resistance Nihon Rinsho. Japanese Journal of Clinical Medicine 49 Suppl: 721-730
Taylor, S.I.; Accili, D.; Cama, A.; Kadowaki, H.; Kadowaki, T.; Imano, E.; Sierra, M.L. 1991: Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance Advances in Experimental Medicine and Biology 293: 197-213
Abed, Y.; Baz, M.; Boivin, G. 2006: Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds Antiviral Therapy 11(8): 971-976
Zhang, Y.; Zhang, C.; Wu, L.; Luo, C.; Guo, X.; Yang, R.; Zhang, Y. 2022: Population genetic structure and evolutionary genetics of Anopheles sinensis based on knockdown resistance (kdr) mutations and mtDNA-COIi gene in China-Laos, Thailand-Laos, and Cambodia-Laos borders Parasites and Vectors 15(1): 229
Kolata, G. 1986: Genetic screening raises questions for employers and insurers Science 232(4748): 317-319
de Serres, F.J. 1989: X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. II. More extensive genetic tests reveal an unexpectedly high frequency of multiple-locus mutations Mutation Research 210(2): 281-290
Tiejun, Z.; Xiaoming, Z.; Jilun, Z.; Yinghu, Z.; Yanhua, R.; Yue, C.; Weiming, G.; Tao, Z.; Qingwu, J. 2009: Fluoroquinolone resistance among Neisseria gonorrhoeae isolates from Shanghai, China: detection of quinolone resistance-determining region mutations Indian Journal of Medical Research 129(6): 701-706
Courcambeck, J.ér.ôm.; Bouzidi, M.; Perbost, R.ég.; Jouirou, B.; Amrani, N.; Cacoub, P.; Pèpe, G.ér.; Sabatier, J.-M.; Halfon, P. 2006: Resistance of hepatitis C virus to NS3-4A protease inhibitors: mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations Antiviral Therapy 11(7): 847-855
Mouroux, M.; Descamps, D.; Izopet, J.; Yvon, A.; Delaugerre, C.; Matheron, S.; Coutellier, A.; Valantin, M.A.; Bonmarchand, M.; Agut, H.; Massip, P.; Costagliola, D.; Katlama, C.; Brun-Vezinet, F.; Calvez, V. 2001: Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy Antiviral Therapy 6(3): 179-183
Totpal, K.; Lapushin, R.; Ananthaswamy, H.N.; Aggarwal, B.B. 1991: In vitro selection of NIH-3T3 cells for resistance to lymphotoxin induces resistance to activated macrophages and enhances tumorigenicity in vivo Lymphokine and Cytokine Research 10(5): 359-367
Gustafsson, K.; Wiman, K.; Emmoth, E.; Larhammar, D.; Böhme, J.; Hyldig-Nielsen, J.J.; Ronne, H.; Peterson, P.A.; Rask, L. 1984: Mutations and selection in the generation of class II histocompatibility antigen polymorphism EMBO Journal 3(7): 1655-1661
Sheldon, J.; Camino, N.; Rodés, B.; Bartholomeusz, A.; Kuiper, M.; Tacke, F.; Núñez, M.; Mauss, S.; Lutz, T.; Klausen, G.; Locarnini, S.; Soriano, V. 2005: Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir Antiviral Therapy 10(6): 727-734
Claflin, J.L.; George, J.; Dell, C.; Berry, J. 1989: Patterns of mutations and selection in antibodies to the phosphocholine-specific determinant in Proteus morganii Journal of Immunology 143(9): 3054-3063
Baas, F.; Jongsma, A.P.; Broxterman, H.J.; Arceci, R.J.; Housman, D.; Scheffer, G.L.; Riethorst, A.; van Groenigen, M.; Nieuwint, A.W.; Joenje, H. 1990: Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line Cancer Research 50(17): 5392-5398
Munnich, A. 1988: Cis- and trans- mutations in genetic diseases Pathologie-Biologie 36(4): 277-283
Peng, S.; Liu, C.; Wang, Y.; Li, Y.; Zhang, C.-c.; Hong, L.; Ou, X.-l.; Sun, H.-y. 2015: Mutations in a Large Pedigree with Y-STR Genetic Markers Fa Yi Xue Za Zhi 31(2): 109-111; 122